abrdn World Healthcare Fund Q1 2025 Commentary
Source: SeekingAlpha
2025-06-03 08:20:00 ET
Summary
- The equity portion of the Fund rose (gross of fees) but underperformed its benchmark over the quarter.
- The top three detractors over the quarter were Novo Nordisk, uniQure and Teva Pharmaceutical Industries.
- The top three positive contributors were Roche Holding, AbbVie and AstraZeneca.
Fund performance
Read the full article on Seeking Alpha
For further details see:
abrdn World Healthcare Fund Q1 2025 Commentary
abrdn Focused U.S. Small Cap Active ETF
NASDAQ: AFSC
AFSC Trading
0.0% G/L:
$36.80 Last:
287 Volume:
$36.80 Open:
